Document ID: chunk:federal_register_of_legislation:C2017C00073:section:42:p4
Version: federal_register_of_legislation:C2017C00073
Segment Type: section
Provision Reference: s 42 (pt 4/8)
Character Range: 62427–65266

(items 10, 11)
Insolvency Law Reform Act 2016                                                11, 2016         29 Feb 2016   Sch 2 (items 43, 44): 1 Mar 2017 (s 2(1) item 3)                                                                 —

(a) The Commonwealth Serum Laboratories Act 1961 was amended by section 3 only of the Statute Law (Miscellaneous Provisions) Act (No. 1) 1985, subsection 2(1) of which provides as follows:
 (1) Subject to this section, this Act shall come into operation on the twenty‑eighth day after the day on which it receives the Royal Assent.
(b) The Commonwealth Serum Laboratories Act 1961 was amended by subsection 41(1) only of the Community Services and Health Legislation Amendment Act (No. 2) 1988, subsection 2(1) of which provides as follows:
 (1) Subject to this section, this Act commences on the day on which it receives the Royal Assent.
(c) Subsection 2(2) of the Commonwealth Serum Laboratories (Conversion into Public Company) Act 1990 provides as follows:
 (2) Subsection 9(2) commences immediately after subsection 44B(3) of the Principal Act as amended by this Act is complied with.
 The date on which the Commonwealth Serum Laboratories Limited certified that the requirements of subsection 44B(3) had been complied with was 22 March 1991.
(d) Subsections 2(1) and (2) of the Tax Law Improvement Act (No. 1) 1998 provide as follows:
 (1) Subject to this section, this Act commences on the day on which it receives the Royal Assent.
 (2) Schedule 2 (except item 3 of it) commences immediately after the commencement of Schedule 1.
 Schedule 1 commenced on Royal Assent.
(e) The Commonwealth Serum Laboratories Act 1961 was amended by Schedule 1 (items 323 and 324) only of the Public Employment (Consequential and Transitional) Amendment Act 1999, subsections 2(1) and (2) of which provide as follows:
 (1) In this Act, commencing time means the time when the Public Service Act 1999 commences.
 (2) Subject to this section, this Act commences at the commencing time.
(f) The Commonwealth Serum Laboratories Act 1961 was amended by Schedule 5 (item 13) only of the Corporate Law Economic Reform Program Act 1999, paragraph 2(2)(b) of which provides as follows:
 (2) The following provisions commence on a day or days to be fixed by Proclamation:
 (b) the items in Schedules 1 to 7 (other than item 18 of Schedule 7);
(g) The Commonwealth Serum Laboratories Act 1961 was amended by Schedule 3 (items
131–145) only of the Corporations (Repeals, Consequentials and Transitionals) Act 2001, subsection 2(3) of which provides as follows:
 (3) Subject to subsections (4) to (10), Schedule 3 commences, or is taken to have commenced, at the same time as the Corporations Act 2001.
(h) The Commonwealth Serum Laboratories Act 1961 was amended by Schedule 1 (items 217 and 218) only of the Financial